A. Gandjour et Kw. Lauterbach, A method for assessing the cost-effectiveness and the break-even point of clinical practice guidelines, INT J TE A, 17(4), 2001, pp. 503-516
Citations number
59
Categorie Soggetti
Health Care Sciences & Services
Journal title
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Assessing the costs and benefits of developing a clinical practice guidelin
e is important because investments in guidelines compete with investments i
n other clinical programs. Despite the considerable number of guidelines in
many industrialized countries, little is known about their costs and cost-
effectiveness. The authors have developed specific measures to determine th
e cost-effectiveness of guidelines, using a German evidence-based guideline
on obesity for the diagnosis and treatment of obese patients as a model. T
he measures are: the number of people needed to cure, the number of people
needed to prevent from developing the disease in question, and the number o
f people to treat in order to break even.